Skip to main content

Table 5 Univariable and multivariable Cox regression analysis for developing AGPN within one year after transplantation according to TMP-SMX prophylaxis administration

From: The impact of trimethoprim-sulfamethoxazole as Pneumocystis jiroveci pneumonia prophylaxis on the occurrence of asymptomatic bacteriuria and urinary tract infections among renal allograft recipients: a retrospective before-after study

  Outcome AGPN P value
HR (95 % CI)
TMP-SMX: univariable model (a) 1.46 (0.78–2.73) 0.239
TMP-SMX: first multivariable model (b) 1.12 (0.57–2.21) 0.751
  1. a: Univariable model: adjusted for only TMP-SMX use
  2. b: First multivariable analysis: adjusted for diabetes mellitus, subtype of immunosuppressive therapy and indwelling urological catheters. Since indwelling urological catheters were the only risk factors for AGPN no second multivariable analysis has been performed